Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06212999
PHASE3

A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa

Sponsor: Incyte Corporation

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate long-term safety and efficacy of povorcitinib in participants with moderate to severe hidradenitis suppurativa who completed the 54 weeks of study treatment within the originating parent Phase 3 studies (INCB 54707-301 \[NCT05620823\] or INCB 54707-302 \[NCT05620836\]).

Official title: A Phase 3, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

617

Start Date

2024-01-30

Completion Date

2026-12-26

Last Updated

2026-08-25

Healthy Volunteers

No

Interventions

DRUG

Povorcitinib

Oral; Tablet

Locations (165)

Investigative Site US303

Phoenix, Arizona, United States

Investigative Site US240

Scottsdale, Arizona, United States

Investigative Site US307

Fort Smith, Arkansas, United States

Investigative Site US214

Rogers, Arkansas, United States

Investigative Site US315

Laguna Niguel, California, United States

Investigative Site US223

Los Angeles, California, United States

Investigative Site US222

Oakland, California, United States

Investigative Site US226

San Diego, California, United States

Investigative Site US309

Clearwater, Florida, United States

Investigative Site US317

Hialeah, Florida, United States

Investigative Site US306

Hollywood, Florida, United States

Investigative Site US320

Hollywood, Florida, United States

Investigative Site US316

Maitland, Florida, United States

Investigative Site US227

Margate, Florida, United States

Investigative Site US204

Miami, Florida, United States

Investigative Site US236

Miami, Florida, United States

Investigative Site US321

North Miami Beach, Florida, United States

Investigative Site US200

Ocala, Florida, United States

Investigative Site US228

Tampa, Florida, United States

Investigative Site US201

Tampa, Florida, United States

Investigative Site US311

Marietta, Georgia, United States

Investigative Site US220

West Dundee, Illinois, United States

Investigative Site US206

Indianapolis, Indiana, United States

Investigative Site US337

Indianapolis, Indiana, United States

Investigative Site US341

Bowling Green, Kentucky, United States

Investigative Site US209

Louisville, Kentucky, United States

Investigative Site US305

Baton Rouge, Louisiana, United States

Investigative Site US207

Metairie, Louisiana, United States

Investigative Site US229

New Orleans, Louisiana, United States

Investigative Site US224

Baltimore, Maryland, United States

Investigative Site US325

Marriottsville, Maryland, United States

Investigative Site US225

Boston, Massachusetts, United States

Investigative Site US304

Boston, Massachusetts, United States

Investigative Site US310

Brighton, Massachusetts, United States

Investigative Site US221

Quincy, Massachusetts, United States

Investigative Site US213

Fort Gratiot, Michigan, United States

Investigative Site US217

Waterford, Michigan, United States

Investigative Site US212

Minneapolis, Minnesota, United States

Investigative Site US302

St Louis, Missouri, United States

Investigative Site US318

Portsmouth, New Hampshire, United States

Investigative Site US230

East Windsor, New Jersey, United States

Investigative Site US324

Kew Gardens, New York, United States

Investigative Site US202

New York, New York, United States

Investigative Site US210

Rochester, New York, United States

Investigative Site US205

Chapel Hill, North Carolina, United States

Investigative Site US215

Bexley, Ohio, United States

Investigative Site US339

Bexley, Ohio, United States

Investigative Site US330

Boardman, Ohio, United States

Investigative Site US314

Cincinnati, Ohio, United States

Investigative Site US312

Cleveland, Ohio, United States

Investigative Site US203

Gahanna, Ohio, United States

Investigative Site US301

Portland, Oregon, United States

Investigative Site US232

Murfreesboro, Tennessee, United States

Investigative Site US235

Arlington, Texas, United States

Investigative Site US218

Bellaire, Texas, United States

Investigative Site US340

Bellaire, Texas, United States

Investigative Site US238

Pflugerville, Texas, United States

Investigative Site US300

Plano, Texas, United States

Investigative Site US234

San Antonio, Texas, United States

Investigative Site US313

Norfolk, Virginia, United States

Investigative Site US308

Spokane, Washington, United States

Investigative Site AU203

Charlestown, New South Wales, Australia

Investigative Site AU205

Kogarah, New South Wales, Australia

Investigative Site AU200

Liverpool, New South Wales, Australia

Investigative Site AU206

Woolloongabba, Queensland, Australia

Investigative Site AU207

Woolloongabba, Queensland, Australia

Investigative Site AU201

Carlton, Victoria, Australia

Investigative Site AU204

Melbourne, Victoria, Australia

Investigative Site AT306

Inssbruck, Austria

Investigative Site AT305

Vienna, Austria

Investigative Site BE300

Brussels, Belgium

Investigative Site BE301

Ghent, Belgium

Investigative Site BE302

Liège, Belgium

Investigative Site BG203

Sofia, Bulgaria

Investigative Site BG202

Sofia, Bulgaria

Investigative Site BG200

Sofia, Bulgaria

Investigative Site BG204

Sofia, Bulgaria

Investigative Site BG201

Stara Zagora, Bulgaria

Investigative Site CA202

Calgary, Alberta, Canada

Investigative Site CA204

Edmonton, Alberta, Canada

Investigative Site CA200

Surrey, British Columbia, Canada

Investigative Site CA301

Winnipeg, Manitoba, Canada

Investigative Site CA205

Fredericton, New Brunswick, Canada

Investigative Site CA304

Barrie, Ontario, Canada

Investigative Site CA308

Hamilton, Ontario, Canada

Investigative Site CA303

London, Ontario, Canada

Investigative Site CA207

Mississauga, Ontario, Canada

Investigative Site CA302

Peterborough, Ontario, Canada

Investigative Site CA208

Richmond Hill, Ontario, Canada

Investigative Site CA307

Montreal, Quebec, Canada

Investigative Site CA206

Saint-Jérôme, Quebec, Canada

Investigative Site CA203

St. John's, Canada

Investigative Site CZ301

Ostrava - Poruba, Czechia

Investigative Site CZ300

Prague, Czechia

Investigative Site DK200

Århus N, Denmark

Investigative Site DK201

Roskilde, Denmark

Investigative Site FR305

Bordeaux, France

Investigative Site FR303

Brest, France

Investigative Site FR205

Dijon, France

Investigative Site FR307

Le Mans, France

And 65 more locations on ClinicalTrials.gov